Search

Spatial working memory can be assessed in mice through the spontaneous alternation T-maze test. The T-maze is a T-shaped apparatus featuring a stem (start arm) and two lateral goal arms (left and right arms). The procedure is based on the natural tendency of rodents to prefer exploring a novel arm over a familiar one, which induces them to alternate the choice of the goal arm across repeated trials. During the task, in order to successfully alternate choices across trials, an animal has to remember which arm had been visited in the previous trial, which makes spontaneous alternation T-maze an optimal test for spatial working memory. As this test relies on a spontaneous behaviour and does not require rewards, punishments or pre-training, it represents a particularly useful tool for cognitive evaluation, both time-saving and animal-friendly. We describe here in detail the apparatus and the protocol, providing representative results on wild-type healthy mice.

Background Maraviroc is an antiretroviral agent and C-C chemokine coreceptor 5 (CCR5) antagonist that is currently used to treat human immunodeficiency virus. CCR5/μ-opioid receptor heterodimerization suggests that maraviroc could be a treatment for oxycodone abuse. We treated rats with maraviroc to explore its effect on oxycodone-seeking and its interference with the analgesic effects of oxycodone. We used resting-state blood-oxygen-level-dependent functional connectivity to assess the effect of maraviroc on oxycodone-enhanced coupling in the reward circuitry and performed behavioural tests to evaluate the effect of maraviroc on oxycodone rewarding properties and on oxycodone-seeking after prolonged abstinence. Methods Two groups of rats were exposed to 8 consecutive days of oxycodone-conditioned place preference training and treatment with maraviroc or vehicle. Two additional groups were trained to self-administer oxycodone for 10 days and then tested for drug seeking after 14 days of abstinence with or without daily maraviroc treatment. We tested the effects of maraviroc on oxycodone analgesia using a tail-flick assay. We analyzed resting-state functional connectivity data using a rat 3-dimensional MRI atlas of 171 brain areas. Results Maraviroc significantly decreased conditioned place preference and attenuated oxycodone-seeking behaviour after prolonged abstinence. The analgesic effect of oxycodone was maintained after maraviroc treatment. Oxycodone increased functional coupling with the accumbens, ventral pallidum and olfactory tubercles, but this was reduced with maraviroc treatment. Limitations All experiments were performed in male rats only. Conclusion Maraviroc treatment attenuated oxycodone-seeking in abstinent rats and reduced functional coupling in the reward circuitry. The analgesic effects of oxycodone were not affected by maraviroc.

Auditory brainstem response (ABR) is used to determine hearing thresholds in children who cannot undergo behavioural testing. Children must remain still during testing, with general anaesthesia (GA) in theatre required for those who cannot. We developed a protocol whereby an ABR was undertaken in a ward environment using only intranasal dexmedetomidine for sedation.Prospective data were collected including the time of sedation onset, ABR duration and arrival to discharge time was recorded and feedback was requested using a questionnaire.Twenty-nine consecutive patients routinely undergoing an ABR.From this pilot study, we demonstrated that intranasal dexmedetomidine could be used successfully to administer safe sedation to all twenty-nine children undergoing an ABR in a ward environment as opposed to theatre.This allowed for faster time to discharge compared to GA, produced what was felt to be a better quality ABR trace, better utilization of a theatre slot, negated the need for GA in a child and created a less stressful experience for both parent and child according to information from feedback questionnaires.

Background The newborn hearing screening programme (NHSP) in England was impacted by the COVID-19 pandemic as screening and audiology services initially stopped outpatients, some parents declined or delayed screening and services struggled to manage capacity with reduced staffing. To monitor the impact Public Health England (PHE) produced weekly data reports. A modelling tool was developed for providers to identify babies still awaiting screening or audiological assessment using the national IT system, SMaRT4Hearing (S4H) and audiology data. This information was used to track screening completion and to support restoration of hearing screening prioritising babies with the greatest chance of permanent childhood hearing impairment (PCHI). Objectives Development of a modelling tool to provide assurance of screening pathway completion, map additional audiology capacity required for babies deferred from screening and prioritise babies that need to be seen first on the basis of risk to minimise delays in the diagnosis of PCHI Methods Weekly data reports extracted from S4H highlighting services with less than 90% coverage and more than 40% of screen referrals awaiting audiology to support commissioner assurance of screening and audiological capacity. Development of a modelling tool for use by screening providers and audiology services Results The programme saw a significant reduction in the number of babies with a completed screen outcome, a slight rise in the number referred to audiology and an increasing number of babies awaiting diagnostic assessment. 1. Coverage Week on week coverage for April 2020 – end of March 2021 compared to April 2019 – March 2020 These data describe an initial drop in coverage at the start of the pandemic from 98.8% to 76.1% with return to near expected levels of coverage over time. There remain more babies that did not have hearing screening compared to the year before. 2. Providers with 40% screening referrals awaiting audiology Tracking of progress by highlighting services meeting these criteria in a national summary report for screening commissioners supported by detailed metrics for each provider. 3. Comparison of diagnosis of permanent childhood hearing impairment The number of unilateral and bilateral cases of permanent childhood hearing impairment diagnosed within the screening programme in 2020/21 is compared to 2019/20 tracking babies deferred for behavioural testing in audiology at the age 7–9 months. Conclusions The COVID-19 pandemic initially impacted the coverage for the newborn screening programme. Coverage has improved over time but there remains a proportion of babies that were not offered initial screening or deferred screening until audiological assessment at 7–9 months of age. These babies are now reaching the age to be seen in audiology. Weekly reporting and use of the modelling tool to support screening and audiology capacity mapping has provided assurance to screening commissioners that the babies at greatest risk have been prioritised. Final full year figures will estimate the potential number of delayed diagnoses of permanent childhood hearing impairment in 2020/21. Paediatric services need to be aware of the impact of COVID-19 on newborn hearing screening and should check if screening has been completed or that babies are referred for audiological assessment.

Graphical abstract, The elevated plus maze is a commonly used and well-validated test of anxiety-related behaviour in rodents. The use of fish in behavioural neuroscience paradigms is increasing, necessitating an equivalent test for studying anxiety-like behaviour in fish. Because behaviour in the elevated plus maze is driven by aversion to open space, the submerged plus maze described here uses transparent walls to elicit similar behaviour in fish. The tendency of fish to explore or avoid the sections of the maze containing transparent walls is used as proxy for anxiety level. This submerged plus maze was designed and validated for convict cichlid (Amatitlania nigrofasciata) fish.

Mistranslated numbers have the potential to cause serious effects, such as financial loss or medical misinformation. In this work we develop comprehensive assessments of the robustness of neural machine translation systems to numerical text via behavioural testing. We explore a variety of numerical translation capabilities a system is expected to exhibit and design effective test examples to expose system underperformance. We find that numerical mistranslation is a general issue: major commercial systems and state-of-the-art research models fail on many of our test examples, for high- and low-resource languages. Our tests reveal novel errors that have not previously been reported in NMT systems, to the best of our knowledge. Lastly, we discuss strategies to mitigate numerical mistranslation., Comment: Findings of ACL, to appear

Despite the rise of Alzheimer's disease (AD) in an ageing population, no cure is currently available for this disorder. This study assessed the role of a natural compound, Antroquinonol, in modifying the progression of AD when administered at the start and/or before appearance of symptoms and when the disease was well established, in a transgenic animal model. Antroquinonol was administered daily for 8 weeks, in 11 week (early stage) and 9 month (late stage) male transgenic mice (3 times Transgenic mice PS1M146V, APPSwe, and tauP301L, 3 ​Tg XAD) and their respective aged controls. Behavioural testing (including Elevated Plus Maze Watermaze, Recognition object testing and Y maze) was performed at the end of the drug administration. In addition AD biomarkers (Amyloid beta 42 (Aβ42), tau and phospho-tau levels), oxidative stress and inflammatory markers, were assessed in tested mice brains after their sacrifice at the end of the treatment. When administered before the start of symptoms at 11 weeks, Antroquinonol treatment at 34 ​mg/kg (D2) and more consistently at 75 ​mg/kg (D3), had a significant effect on reducing systemic inflammatory markers (Interleukin 1, IL-1β and TNF-α) and AD biomarker (Amyloid Beta 42, Aβ42 and tau) levels in the brain. The reduction of behavioural impairment reported for 3TgXAD mice was observed significantly for the D3 drug dose only and for all behavioural tests, when administered at 11 weeks. Similarly, beneficial effects of Antroquinonol (at higher dose D3) were noted in the transgenic mice in terms of AD biomarkers (tau and phosphorylated-tau), systemic inflammatory (IL-1β), brain anti-inflammatory (Nrf2) and oxidative (3-Nitrotyrosine, 3NT) markers. Improvement of memory impairment was also reported when Antroquinonol (D3) was administered at late stage (9 months). Since Antroquinonol has been used without adverse effects in previous successful clinical trials, this drug may offer a new avenue of treatment to modify AD development and progression.

This study tested the idea that stuttering is caused by over-reliance on auditory feedback. The theory is motivated by the observation that many fluency-inducing situations, such as synchronised speech and masked speech, alter or obscure the talker’s feedback. Typical speakers show ‘speaking-induced suppression’ of neural activation in superior temporal gyrus (STG) during self-produced vocalisation, compared to listening to recorded speech. If people who stutter over-attend to auditory feedback, they may lack this suppression response. In a 1.5T fMRI scanner, people who stutter spoke in synchrony with an experimenter, in synchrony with a recording, on their own, in noise, listened to the experimenter speaking and read silently. Behavioural testing outside the scanner demonstrated that synchronising with another talker resulted in a marked increase in fluency regardless of baseline stuttering severity. In the scanner, participants stuttered most when they spoke alone, and least when they synchronised with a live talker. There was no reduction in STG activity in the Speak Alone condition, when participants stuttered most. There was also strong activity in STG in response to the two synchronised speech conditions, when participants stuttered least, suggesting that either stuttering does not result from over-reliance on feedback, or that the STG activation seen here does not reflect speech feedback monitoring. We discuss this result with reference to neural responses seen in the typical population.

Neuroimaging has advanced our understanding of human psychology using reductionist stimuli that often do not resemble information the brain naturally encounters. It has improved our understanding of the network organization of the brain mostly through analyses of ‘resting-state’ data for which the functions of networks cannot be verifiably labelled. We make a ‘Naturalistic Neuroimaging Database’ (NNDb v1.0) publically available to allow for a more complete understanding of the brain under more ecological conditions during which networks can be labelled. Eighty-six participants underwent behavioural testing and watched one of 10 full-length movies while functional magnetic resonance imaging was acquired. Resulting timeseries data are shown to be of high quality, with good signal-to-noise ratio, few outliers and low movement. Data-driven functional analyses provide further evidence of data quality. They also demonstrate accurate timeseries/movie alignment and how movie annotations might be used to label networks. The NNDb can be used to answer questions previously unaddressed with standard neuroimaging approaches, progressing our knowledge of how the brain works in the real world., Measurement(s) functional brain measurement • Behavioral Assessment Technology Type(s) functional magnetic resonance imaging • NIH Toolbox Factor Type(s) movie Sample Characteristic - Organism Homo sapiens Sample Characteristic - Environment laboratory facility Machine-accessible metadata file describing the reported data: 10.6084/m9.figshare.12869855

In the absence of established best practice standards in the probiotic field for reducing the risk of bacterial transfer between experimental groups, we developed protocols and methods to ensure the highest quality and interpretability of results from animal studies, even when performed in non-conventional animal care facilities. We describe easily implementable methods for reducing cross-contamination during animal housing, behavioural testing, and euthanasia, along with highlighting protocols for contamination detection in experimental subjects and laboratory areas using qPCR. In light of the high cross-contamination risks between animals during experiments involving probiotics, constant vigilance in animal care and research protocols is critical to ensure valid and reliable research findings.

Autism spectrum disorders (ASD) are complex neurodevelopmental disorders that are caused by genetic and/or environmental impacts, often probably by the interaction of both. They are characterised by deficits in social communication and interaction and by restricted and repetitive behaviours and interests from early childhood on, causing significant impairment. While it is clear that no animal model captures the full complexity of ASD in humans, genetic models are extremely useful for studying specific symptoms associated with ASD and the underlying cellular and molecular mechanisms. In this review we summarize the behavioral paradigms used in rodents to model ASD symptoms as they are listed in the DSM-5. We then review existing genetic rodent models with disruptions in ASD candidate genes, and we map their phenotypes onto these behavioural paradigms. The goal of this review is to give a comprehensive overview on how ASD symptoms can be studied in animal models and to give guidance for which animal models are appropriate to study specific symptom clusters.

Environmental contaminants such as metal ions can have detrimental effects on aquatic organisms at the molecular, organismal and population levels. In the present work, we examined the interactive effect of Cu(II) and conspecific alarm substance on zebrafish behavioural responses utilizing the novel tank diving assay. To this end, 3 novel tank diving tests (on day 0, 3 and 10 of the experimental phase) were conducted on zebrafish in 4 experimental groups: (1) control: no Cu(II) and no alarm substance, (2) Cu(II) only: exposed to 0.78 μM Cu(II) (25 % of the 240 h LC50) in the home tank for 10 days, (3) alarm substance only: exposed to alarm substance for 6 min concomitant with behavioural testing, and (4) Cu(II) + alarm substance: exposed to 0.78 μM Cu(II) in the home tank for 10 days and treated with alarm substance for 6 min during the behavioural testing. Results showed robust habituation response of zebrafish. Exposure to Cu(II) did not affect the behavioural phenotypes of zebrafish in the novel tank diving test or habituation responses. Alarm substance treatment evoked strong anxiety-like behaviour. Finally, zebrafish in the Cu(II) + alarm substance group lost their sensitivity to alarm substance in repeated novel tank assays throughout the concomitant Cu(II) exposure; this observation is tentatively ascribed to Cu(II)-induced olfactory impairment.

Ferrets (Mustela putorius furo) are a valuable animal model used in biomedical research. Like many animals, ferrets undergo significant variation in body weight seasonally, affected by photoperiod, and these variations complicate the use weight as an indicator of health status. To overcome this requires a better understanding of these seasonal weight changes. We provide a normative weight data set for the female ferret accounting for seasonal changes, and also investigate the effect of fluid regulation on weight change. Female ferrets (n = 39) underwent behavioural testing from May 2017 to August 2019 and were weighed daily, while housed in an animal care facility with controlled light exposure. In the winter (October to March), animals experienced 10 hours of light and 14 hours of dark, while in summer (March to October), this contingency was reversed. Individual animals varied in their body weight from approximately 700 to 1200 g. However, weights fluctuated with light cycle, with animals losing weight in summer, and gaining weight in winter such that they fluctuated between approximately 80% and 120% of their long-term average. Ferrets were weighed as part of their health assessment while experiencing water regulation for behavioural training. Water regulation superimposed additional weight changes on these seasonal fluctuations, with weight loss during the 5-day water regulation period being greater in summer than winter. Analysing the data with a Generalised Linear Model confirmed that the percentage decrease in weight per week was relatively constant throughout the summer months, while the percentage increase in body weight per week in winter decreased through the season. Finally, we noted that the timing of oestrus was reliably triggered by the increase in day length in spring. These data establish a normative benchmark for seasonal weight variation in female ferrets that can be incorporated into the health assessment of an animal's condition.

In recent years our understanding of Parkinson's disease has expanded both in terms of pathological hallmarks as well as relevant genetic influences. In parallel with the aetiological discoveries a multitude of PD animal models have been established. The vast majority of these are rodent models based on environmental, genetic and mechanistic insight. A major challenge in many of these models is their ability to only recapitulate some of the complex disease features seen in humans. Although symptom alleviation and clinical signs are of utmost importance in therapeutic research many of these models lack comprehensive behavioural testing. While non-motor symptoms become increasingly important as early diagnostic markers in PD, they are poorly characterized in rodents. In this review we look at well-established and more recent animal models of PD in terms of behavioural characterization and discuss how they can best contribute to progression in Parkinson's research.

Stroke is a common and devastating disease worldwide. Over the last two decades, many therapeutic approaches to ameliorate ischaemic stroke have been promising in animal studies but failed when transferred to the clinical situation. One of the possible explanations for these failures is the widespread use of animal models of cerebral ischemia that do not mimic the pathology encountered in the clinic. Accordingly, many expert committees recommended the integration of higher order species such as non-human primates in pre-clinical stroke studies. The common marmoset (Callithrix jacchus), a small New World monkey, start to stand out in the neuroscience field as a good compromise between larger primates and rodents. In this review, we discuss the relevance of the use of the marmoset in stroke studies. We will focus on behavioural tests developed in this species to assess sensorimotor deficits and their recovery during acute and chronic stages of brain ischaemia. The aim of this appraisal is to provide a comprehensive overview of the existing approaches to induce stroke in the marmoset as well as the paradigms for behavioural testing in this species. The data summarized in this review should contribute to the improvement of future stoke studies in the marmoset and accordingly improve the translation of the results from bench to bed.

A reliable self-report measure to assess the broad spectrum of face recognition ability (FRA) from developmental prosopagnosia (DP) to super-recognition would make a valuable contribution to initial screening of large populations. We examined the performance of 96 naive participants and seven super-recognisers (SRs) using a range of face and object processing tasks and a newly developed 20-item questionnaire, the Stirling Face Recognition Scale (SFRS). Overall, our findings suggest that young adults have only moderate insight into their FRA, but those who have been previously informed of their (exceptional) performance, the SRs, estimate their FRA accurately. Principal component analysis of SFRS yielded two components. One loads on questions about low ability and correlates with perceptual tasks, and one loads on questions about high FRA and correlates with memory for faces. We recommend that self-report measures of FRA should be used in addition to behavioural testing, to allow for cross-study comparisons, until new, more reliable instruments of self-report are developed. However, self-report measures should not be solely relied upon to identify highly skilled individuals. Implications of these results for theory and applied practice are discussed.

Testing and training animals in motor and related tasks is a cornerstone of pre-clinical behavioural and rehabilitative neuroscience. Yet manually testing and training animals in these tasks is time consuming and analyses are often subjective. Consequently, there have been many recent advances in automating both the administration and analyses of animal behavioural training and testing. This review is an in-depth appraisal of the history of, and recent developments in, the automation of animal behavioural assays used in neuroscience. We describe the use of common locomotor and non-locomotor tasks used for motor training and testing before and after nervous system injury. This includes a discussion of how these tasks help us to understand the underlying mechanisms of neurological repair and the utility of some tasks for the delivery of rehabilitative training to enhance recovery. We propose two general approaches to automation: automating the physical administration of behavioural tasks (i.e., devices used to facilitate task training, rehabilitative training, and motor testing) and leveraging the use of machine learning in behaviour analysis to generate large volumes of unbiased and comprehensive data. The advantages and disadvantages of automating various motor tasks as well as the limitations of machine learning analyses are examined. In closing, we provide a critical appraisal of the current state of automation in animal behavioural neuroscience and a prospective on some of the advances in machine learning we believe will dramatically enhance the usefulness of these approaches for behavioural neuroscientists.

The spatial auditory change complex (ACC) is a cortical response elicited by a change in place of stimulation. There is growing evidence that it provides a useful objective measure of electrode discrimination in cochlear implant (CI) users. To date, the spatial ACC has only been measured in relatively experienced CI users with one type of device. Early assessment of electrode discrimination could allow auditory stimulation to be optimized during a potentially sensitive period of auditory rehabilitation. In this study we used a direct stimulation paradigm to measure the spatial ACC in both pre- and post-lingually deafened adults. We show that it is feasible to measure the spatial ACC in different CI devices and as early as 1 week after CI switch-on. The spatial ACC has a strong relationship with performance on a behavioural discrimination task and in some cases provides information over and above behavioural testing. We suggest that it may be useful to measure the spatial ACC to guide auditory rehabilitation and improve hearing performance in CI users.

Behavioural testing allows to exclude dogs that are fearful and aggressive from the breeding population, but relatively little is known about the effectiveness of such strategies in practice. From 2001 till 2009 parent purebred Dutch Rottweilers had to pass the Socially Acceptable Behaviour (SAB)-test for their offspring to obtain a pedigree certificate. We evaluated if this breeding policy of excluding fearful and aggressive Rottweilers, as diagnosed by the SAB-test, indeed reduced the prevalence of fear and aggression in the Dutch Rottweiler population. Owner-reported assessments of their dogs' behaviour were compared between groups of Rottweilers with or without pedigree certificates, assuming the Rottweiler look-a-likes to represent the control condition of no breeding policy regarding fear and aggression. A total of 822 Rottweiler owners filled out the Canine Behavioural Assessment and Research Questionnaire (C-BARQ) on problem behaviour, including 7 behavioural categories related to fear and aggression. Problem behaviour prevalence and explanatory factors were investigated by multivariable logistic regression.The prevalence of Stranger-directed fear (P.

Purpose of Review Individuals with autism spectrum disorders (ASD) commonly also suffer from gastrointestinal (GI) dysfunction; however, few animal model studies have systematically examined both ASD and GI dysfunction. In this review, we highlight studies investigating GI dysfunction and alterations in gut microbiota in animal models of ASD with the aim of determining if routinely used microbiology and enteric neurophysiology assays could expand our understanding of the link between the two. Recent Findings Gut–brain axis research is expanding, and several ASD models demonstrate GI dysfunction. The integration of well-established assays for detecting GI dysfunction into standard behavioural testing batteries is needed. Summary Advances in understanding the role of the gut–brain axis in ASD are emerging; however, we outline standard assays for investigating gut–brain axis function in rodents to strengthen future phenotyping studies. Integrating these findings to the field of animal behaviour is one of the next major challenges in autism research.

Fluoxetine (Prozac™) is designed to alter human behaviour; however, because many physiological pathways are conserved across vertebrates, this drug may affect the behaviour of fish living in fluoxetine-polluted environments. Although a number of studies have used behaviour to document the sub-lethal effects of fluoxetine, the repeatability of these effects across experiments, across behavioural contexts, and over different exposure durations are rarely considered. Here, we conducted two experiments and assessed how fluoxetine exposure affected a range of fitness-related behaviours in wild round goby (Neogobius melanostomus). We found that fluoxetine impacts round goby behaviour at high (40 μg/l) doses, but not at environmentally relevant low doses (1 μg/l). In both experiments, an acute 3-day exposure to fluoxetine reduced round goby aggression in multiple behavioural contexts, but had no detectable effect on overall activity or social affiliative behaviour. While a chronic 28-day exposure to fluoxetine exposure still reduced aggression, this reduction was only detectable in one behavioural context. Our findings demonstrate the importance of repeated behavioural testing (both between and within experiments) and contribute to a growing body of literature evaluating the effects of fluoxetine and other pharmaceuticals on animal behaviour.

Several studies have used behavioural tests to characterise sows regarding their maternal performance. These studies have always chosen a selection of behavioural tests and the combination of tests varied between the studies. In the present study, 47 sows were tested in week 2 and 4 of lactation in five successive maternal tests, which were conducted in their home pens and in a test arena. The sows’ reaction to piglet stress signals, separation from and reunion with their piglets were tested. The behavioural parameters observed in these maternal tests were examined by means of a factor analysis to identify redundancies in behavioural parameters. Five factors were extracted, explaining together 89.2 % of the total variance, of which Factor 1 explains 33.5 %, Factor 2 18.4 %, Factor 3 14.5 %, Factor 4 12.6 % and Factor 5 10.2 %. The interpretation of the factor loadings revealed four underlying maternal factors: communication, care, contact and local attachment. Communication, thus vocalisation, was extracted by the factor analysis as the most important maternal factor and is used in sows to call their piglets in threatening situations as in the separation test and the piglet scream test. Furthermore, communication plays a role for the maternal contact and care factors. Sows used vocalisation to contact their piglets using nose-to-nose contacts, which were observed in the reunion test and also in the piglet scream test. With regard to the care factor, sows use vocalisation to call their piglets for nursing and to synchronise nursing with other sows. The willingness to stay with their piglets, thus local attachment to their piglets, was shown by sows in the separation and reunion test in the test arena and the piglet scream test. Furthermore, the factor analysis proves that single maternal tests can also combine more than one maternal factor and that the experimental environment in which the tests are placed influences the significance of the tests. The present results demonstrate the complexity and diversity of maternal behaviour.

Introduction Within the Early Hearing Detection and Intervention (EHDI) pathway, which includes the processes of screening, diagnosis and intervention for paediatric hearing loss, paediatric diagnostic audiology involves a battery of specific tests and procedures. International studies have highlighted a golden standard for diagnosis of paediatric hearing loss as based on the Joint Committee of Infant Hearing (2007) diagnostic guidelines, closely resembling the HPCSA diagnostic guidelines. There are limited South African studies on the processes and protocols followed in diagnostic paediatric audiology. Objectives This study aims to provide a comparison for how the tests used for diagnosis of paediatric hearing loss in South Africa (within both the public and private healthcare sectors) compare to the HPCSA recommended diagnostic guidelines. Methods A retrospective record review of paediatric clients with hearing loss (recruited through nonprobability convenience sampling) was conducted. This study is part of a longitudinal study of 711 deaf or hard of hearing children referred to the HI HOPES early intervention programme from September 2006 to December 2011. Diagnostic data from audiology reports of 117 children between 0 and 36 months were coded and analysed. Results Large variation was found in the tests included in the diagnostic audiology reports. For 22 children (19%) a comprehensive test battery was used. Health Professions Council of South Africa (HPCSA) recommended guidelines for diagnostic testing were not followed in any of the records analysed. Components of the HPCSA recommended test battery most frequently omitted was bone conduction testing. For both electrophysiology and behavioural testing, there was limited frequency specificity information. This exclusion of information is evidence of deficiencies in data recording and management, as well as having an effect on accuracy of classification of degree and type of hearing loss. Conclusion There are gaps in age-appropriate assessment protocols, which will have an effect on accurate differential diagnosis of paediatric hearing loss. Reasons for not including all testing components of the HPCSA recommended guidelines, as well as the possibility of developing guidelines more relevant to a developing world context, should be explored. There might be a need for. The impact of South African specific factors that have an effect on provision of accurate paediatric diagnostic audiology services should be determined.

In this chapter, a number of key ethical issues associated with the recent emergence of the related fields of neuromarketing and sensory marketing are reviewed. Now that these new techniques are really starting to show their predictive mettle relative to other, more traditional, consumer psychology/behavioural testing approaches to marketing, questions around the ethics of stimulating the brain’s “buy button” start to raise their head. Here, I want to question what exactly is so special, and so worrying, about “looking inside the mind of the consumer”. I will argue that public fears around the dangers of neuromarketing have been overblown, at least up until the present time and, as far as I can see, for the foreseeable future. I do, though, want to raise a number of concerns around the growing influence of sensory marketing on our behaviour, focusing, in particular, on the world of food and drink marketing. Ultimately, I believe that the consumer of tomorrow may well have much to fear from the emerging neuroscience-inspired approaches to sensory marketing. In fact, before too long, we may all start to find ourselves being sensorially “nudged” into a range of less healthy food behaviours. As such, establishing clear ethical guidelines will, I believe, become an increasingly important issue for those working in the field.

The 3xTg-AD mouse model of Alzheimer's disease (AD) has both amyloid beta plaque and tau tangle pathology. However, the results of behavioural testing with these mice have been inconsistent due to age- and sex-related differences, as well as differences in the difficulty of the tests used to measure cognitive function. In order to better understand the sex- and age-related spatial working memory deficits in the 3xTg-AD mice compared to their B6129S/F2 wildtype controls, we tested 4 and 7-month-old males and females and 13-month-old females in the Hebb-Williams maze. In the acquisition phase, the 3xTg-AD mice performed better than the WT controls, but the females of both genotypes showed motivational deficits; often returning to the start box and not eating the food reward, thus taking longer than males to meet the criterion for acquisition. The 3xTg-AD mice showed more working memory deficits than WT mice during the test phase, and the difference increased as the problems increased in difficulty. The results of this study indicate that female 3xTg-AD mice may have motivational deficits in tests using food reward and that the cognitive deficits of the 3xTg-AD mice are not apparent when the tests are too easy; the more difficult the task, the more deficits are shown in the 3xTg-AD mice compared to WT controls. Thus, the inconsistency in previous results may result from differences in motivation and in test difficulty and these must be considered when evaluating cognitive deficits in the 3xTg-AD mice.

Aquatic organisms in pharmacology and toxicology research are often exposed to compounds in isolation prior to physiological or behavioural testing. Recent evidence suggests that the presence of conspecifics during a stressful event can modulate behavioural outcomes (called ‘social buffering’) when testing occurs within the same context. It is unknown, however, whether the social environment during exposure interacts with the efficacy of anxiety-altering substances when subsequently tested in the absence of conspecifics. In this study, zebrafish were individually exposed to habitat water or ethanol (1.0% vol/vol) while untreated conspecifics were visually present or absent during dosing. Using the novel object approach test, a validated test of boldness and anxiety-like behaviour, we observed significantly greater effects of ethanol in isolated fish, compared to fish with a view of conspecifics during dosing. These results were not explained by altered locomotion during exposure, which might otherwise increase drug uptake. This highlights the need to consider the social environment during exposure when conducting and interpreting behavioural research involving drug or toxicant exposure.